(Press-News.org) ATS 2011, DENVER – Removing enlarged tonsils and adenoids may help prevent high blood pressure and heart damage in children who suffer from obstructive sleep apnea (OSA), according to a study conducted at Cincinnati Children's Hospital Medical Center. In some children with OSA, adenotonsillectomy can result in significantly lower blood pressure within 24 months of the procedure.
The results will be presented at the ATS 2011 International Conference in Denver.
Children with enlarged tonsils and adenoids are particularly prone to developing OSA, said study lead author Lisa Burns, MD, (Pulmonary Fellow at Cincinnati Children's Hospital Medical Center). And, in children and adults, OSA has been linked with elevations in both daytime and nighttime blood pressure. OSA can also interfere with the normal "dip" in blood pressure levels that occur during sleep. Persistent elevations in blood pressure can result in organ damage, including heart damage.
"Our study emphasizes the importance of treating severe sleep apnea in order to prevent persistent elevation in blood pressure and end-organ damage," Dr. Burns said. "We also show that during sleep, diastolic blood pressure, the measurement of your blood pressure when the heart is relaxing, is more sensitive to the effects of sleep apnea than other measures of blood pressure."
Dr. Burns and colleagues evaluated 115 children between the ages of 7 and 13 years, including 28 patients with mild OSA, 27 with severe OSA and 60 healthy controls. The subjects were evaluated for level of OSA using polysomnography, a diagnostic test used to measure breathing during periods of sleep. All OSA subjects had enlarged adenoids and tonsils and underwent adenotonsillectomy. Blood pressure, rest and activity levels, and heart size were measured at the beginning of the study and during follow-up at 12 to 24 months.
At follow-up, researchers found blood pressure levels during sleep decreased following adenotonsillectomy when compared with measurements at baseline. The procedure also restored the normal nighttime "dip" in blood pressure relative to daytime blood pressure, Dr. Burns said.
In addition, in a subset of children with moderate to severe sleep apnea, there was a decrease in heart size after adenotonsillectomy.
Dr. Burns said the results are similar to those obtained from studies of adults with OSA.
"We expected to see changes based on what we know about adults with sleep apnea and its effect on blood pressure," she said. "We know that children with sleep apnea tend to have higher blood pressures than children without sleep apnea, even if these elevations still fall within a normal range. However this is the first study to evaluate how treatment of sleep apnea impacts blood pressure and heart size in a pediatric population who are free from other diseases, which may also contribute to elevations in blood pressure.
Treating OSA in childhood is especially critical, Dr. Burns noted.
"Children who have elevated blood pressure throughout childhood will often go on to develop high blood pressure in adulthood," she said. "Adults with high blood pressure are at risk for other cardiovascular diseases, such as heart attacks, stroke, and heart failure. By identifying and treating elevations in blood pressure at an earlier age through treatment of OSA, we hope to prevent development of cardiovascular disease in childhood and later in life."
Future studies should investigate the mechanisms leading to blood pressure changes with sleep apnea, she added.
###
"Effect Of Adenotonsillectomy On Activity Adjusted Ambulatory Blood Pressure And Left Ventricular Geometry In Children With Obstructive Sleep Apnea" (Session B15, Monday, May 16, 8:15-20:45 a.m., Centennial Ballroom D (Third Level), Hyatt Regency Denver; Abstract 20107)
* Please note that numbers in this release may differ slightly from those in the abstract. Many of these investigations are ongoing; the release represents the most up-to-date data available at press time.
Simple surgical procedure may help prevent heart damage in children
2011-05-17
ELSE PRESS RELEASES FROM THIS DATE:
Can vital signs predict cardiac arrest on the wards? Yes, but...
2011-05-17
ATS 2011, DENVER--Researchers at the University of Chicago Medical Center attempting to identify the vital signs that best predict those hospitalized patients at greatest risk for cardiac arrest found that a composite index used in some hospitals to activate a rapid response team and by emergency room physicians to assess the likelihood of a patient dying was a better predictor of cardiac arrest than any single vital sign.
However, because the composite index known as Modified Early Warning Score (MEWS) included vital signs that are poor predictors of cardiac arrest, ...
Smoke-related chemical discovered in the atmosphere could have health implications
2011-05-17
Cigarette smoking, forest fires and woodburning can release a chemical that may be at least partly responsible for human health problems related to smoke exposure, according to a new study by NOAA researchers and their colleagues.
Using a custom mass spectrometer designed by the researchers, the NOAA-led team was able get the first look at levels of the chemical, isocyanic acid, in the atmosphere. Isocyanic acid has been difficult to detect with conventional measurement techniques.
"We found isocyanic acid in a number of places, from air in downtown Los Angeles and ...
Stopping HIV transmission with a molecular barrier
2011-05-17
Using a technique that silences genes promoting infection, researchers have developed a novel, topically-applied molecular microbicide capable of preventing HIV transmission. The microbicide is predicted to have long-lasting effects in mice, opening the door to developing an intravaginal microbicide that could protect women against HIV infection potentially for weeks at a time and bolster public health efforts to halt the spread of HIV/AIDS.
The study, led by Lee Adam Wheeler and Judy Lieberman, MD, PhD, of the Immune Disease Institute and the Program in Cellular and ...
Leucine deprivation proves deadly to malignant melanoma cells
2011-05-17
CAMBRIDGE, Mass. (May 16, 2011) – Whitehead Institute researchers have found that depriving human melanoma cells of the essential amino acid leucine can be lethal to the cells, suggesting a possible strategy for therapeutic intervention.
The researchers observed the effect in melanoma cells with a mutation in the RAS/MEK signaling pathway—the most common mutation found in the deadliest form of skin cancer.
Leucine is one of nine essential amino acids humans must ingest, as we are unable to synthesize them. These nine, along with 12 non-essential amino acids, are the ...
Follow-up rehabilitation boosts survival odds for angioplasty patients
2011-05-17
Patients who undergo a procedure to unblock a coronary artery are more likely to survive longer if they participate in structured follow-up care, according to research in Circulation: Journal of the American Heart Association.
In their 14-year analysis, researchers discovered a 46 percent relative reduction in death from all causes in patients who participated in cardiac rehabilitation following angioplasty.
The study focused on patients treated with percutaneous coronary interventions (PCI), commonly known as angioplasty. Using data from a Mayo Clinic registry of PCI ...
Stem cells reverse disease in a model of Parkinson's disease
2011-05-17
A team of researchers — led by Sang-Hun Lee, at Hanyang University, Republic of Korea, and Kwang-Soo Kim, at Harvard Medical School, Belmont, — has now compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and identified a stem cell population that they believe could be clinically relevant.
Parkinson disease results from the progressive loss of a specific subpopulation of nerve cells. Current treatments provide only relief from the symptoms of the disease and cannot reverse the nerve cell loss. ...
An APT(amer) approach to preventing HIV transmission
2011-05-17
The HIV epidemic is continuing spread and efforts to develop a vaccine that protects against infection are still showing limited promise. Therefore, researchers are seeking to develop alternative approaches to block HIV transmission. One such strategy is vaginal application of an agent known as a microbicide, which works to kill the virus at the site of entry into the body. A team of researchers, led by Judy Lieberman, at Harvard Medical School, Boston, has now developed a new agent that they hope could be used as the active ingredient in a microbicide to prevent HIV transmission.
HIV ...
JCI online early table of contents: May 16, 2011
2011-05-17
EDITOR'S PICK: Stem cells reverse disease in a model of Parkinson disease
A team of researchers — led by Sang-Hun Lee, at Hanyang University, Republic of Korea, and Kwang-Soo Kim, at Harvard Medical School, Belmont, — has now compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and identified a stem cell population that they believe could be clinically relevant.
Parkinson disease results from the progressive loss of a specific subpopulation of nerve cells. Current treatments provide only ...
UF researchers link oceanic land crab extinction to colonization of Hawaii
2011-05-17
GAINESVILLE, Fla. --- University of Florida researchers have described a new species of land crab that documents the first crab extinction during the human era.
The loss of the crab likely greatly impacted the ecology of the Hawaiian Islands, as land crabs are major predators, control litter decomposition and help in nutrient cycling and seed dispersal. Their disappearance was caused by the arrival of humans to the islands and resulted in large-scale changes in the state's ecosystem. Researchers said the full impact of the extinction on Hawaii is unknown, but they are ...
Scientists identify livestock genes to unlock protection against one of Africa's oldest animal plagues
2011-05-17
Contact: Jeff Haskins
jhaskins@burnesscommunications.com
ILRI
Scientists identify livestock genes to unlock protection against one of Africa's oldest animal plagues
NAIROBI, KENYA (16 May 2011)—An international research team using a new combination of approaches has found two genes that may prove of vital importance to the lives and livelihoods of millions of farmers in a tsetse fly-plagued swathe of Africa the size of the United States. The team’s results were published today in the Proceedings of the National Academy of Sciences (PNAS).
The research, aimed at ...